Neural circuits are interconnected networks of neurons that process information and control brain functions. In neurodegenerative diseases, circuit dysfunction is a critical feature that leads to characteristic cognitive and motor deficits. Understanding how these circuits are affected provides crucial insights into disease mechanisms and informs therapeutic development across Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders[1].
The human brain contains approximately 86 billion neurons, organized into circuits that range from simple three-neuron reflex arcs to vast networks spanning multiple cortical and subcortical regions. These circuits are not static—they undergo constant plasticity in response to activity, injury, and disease. In neurodegeneration, the selective vulnerability of specific neuronal populations and their connections creates a stereotyped pattern of circuit dysfunction that defines the clinical phenotype of each disease.
Circuit dysfunction in neurodegeneration is not merely a consequence of neuronal death—it actively contributes to disease progression through several mechanisms: loss of trophic support between connected neurons, trans-synaptic propagation of pathological proteins (such as tau and alpha-synuclein), homeostatic plasticity failures, and circuit-level hyperexcitability or hypoexcitability. Understanding these mechanisms at the circuit level has become a central focus of modern neurodegeneration research[2].
Memory circuits encompass the hippocampal formation (dentate gyrus, CA3, CA1, subiculum), entorhinal cortex, and parahippocampal regions, which are essential for episodic memory formation, consolidation, and retrieval. The hippocampus receives multimodal input from the entorhinal cortex through the perforant path and projects to various cortical and subcortical structures through the fornix, creating a distributed memory network[3].
The hippocampal circuit is organized as a trisynaptic pathway: entorhinal cortex → dentate gyrus → CA3 (Mossy fiber pathway) → CA1 (Schaffer collateral pathway) → subiculum and entorhinal cortex. This loop structure supports pattern separation (distinguishing similar memories) and pattern completion (retrieving complete memories from partial cues), functions that are early compromised in AD.
Motor circuits include the basal ganglia-cortical loops and cerebellar pathways that work together to coordinate movement, from voluntary actions to habit formation and motor learning. The basal ganglia receives input from the entire cerebral cortex, processes it through direct and indirect pathways, and outputs to the thalamus and brainstem motor centers[4].
Executive circuits involve the prefrontal cortex and its extensive connections to other cortical and subcortical structures, enabling planning, decision-making, working memory, and cognitive control over behavior. These circuits are particularly vulnerable in frontotemporal dementia and PD dementia[5].
Sensory circuits process information from peripheral receptors through thalamic relays to primary sensory and association cortices. While traditionally considered peripheral to neurodegeneration, sensory circuits show significant dysfunction in PD (auditory, olfactory, somatosensory), AD (visual-spatial processing through the ventral stream), and are early indicators of disease in multiple conditions.
Brainstem and autonomic circuits regulate vital functions including cardiovascular control, respiratory rhythm, sleep-wake cycles, and arousal. These circuits are differentially affected in MSA (autonomic failure), PSP (vertical gaze and postural control), and PD (REM sleep behavior disorder, constipation)[6].
Neural circuits follow several organizational principles that explain their selective vulnerability in neurodegeneration:
Hierarchical processing: Information flows from primary sensory areas through association areas to higher-order integrative regions. Pathology that travels trans-synaptically (like tau and alpha-synuclein) follows these hierarchical pathways, explaining the stereotyped progression of pathology in AD and PD[7].
Convergence and divergence: A small number of hub neurons (such as layer 5 pyramidal neurons) receive input from thousands of presynaptic partners and project to multiple downstream targets, making them particularly vulnerable to trans-synaptic pathology.
Network-level oscillation: Circuits generate oscillatory activity at different frequencies (delta: 1-4 Hz, theta: 4-8 Hz, alpha: 8-12 Hz, beta: 13-30 Hz, gamma: 30-100 Hz) that coordinates information processing across brain regions. In neurodegeneration, these oscillations are disrupted—PD patients show excessive beta-band synchrony in the basal ganglia, while AD patients show reduced gamma-band coordination in cortical circuits.
Neuromodulatory gain: Cholinergic, dopaminergic, noradrenergic, and serotonergic systems provide broadcast modulation to distributed circuits, adjusting their responsiveness and plasticity. Loss of these modulatory systems (as occurs early in AD with locus coeruleus noradrenergic degeneration) has circuit-wide effects beyond the direct loss of modulatory neurons.
Alzheimer's disease targets memory circuits with remarkable specificity, beginning with the locus coeruleus and entorhinal cortex decades before clinical symptoms appear[7:1]. The progression of tau pathology follows connected circuits in a predictable pattern[2:1]:
Stage 1-2 (Preclinical): Locus coeruleus shows tau accumulation; entorhinal cortex and hippocampal CA1 neurons develop neurofibrillary tangles. Synaptic dysfunction begins in the perforant path.
Stage 3 (Mild Cognitive Impairment): Spreads to the hippocampus proper, particularly CA1 and subiculum. Memory encoding deficits become clinically apparent.
Stage 4 (Mild AD): Progresses to limbic structures including the amygdala. Episodic memory deficits are prominent.
Stage 5-6 (Moderate-Severe AD): Reaches isocortical association areas (inferior temporal, prefrontal, posterior cingulate). Visuospatial deficits, language problems, and executive dysfunction emerge.
The hippocampal-entorhinal circuit dysfunction in early AD manifests as:
Parkinson's targets motor circuits within the basal ganglia, but the disease also affects non-motor circuits throughout the brain[4:1]:
Motor Circuit Disruption: Loss of dopaminergic neurons in the substantia nigra pars compacta disrupts the normal balance between the direct and indirect pathways within the basal ganglia motor circuit. This creates excessive output from the globus pallidus internus and substantia nigra pars reticulata, hyper-inhibiting the thalamus and reducing excitatory drive to the motor cortex.
Basal Ganglia-Cortical Loop Architecture[9]:
Non-Motor Circuit Involvement:
FTD affects frontal and temporal cortical circuits, with specific circuit targeting defining the clinical variants[5:1]:
Behavioral Variant FTD (bvFTD): Affects prefrontal circuits, particularly the dorsolateral prefrontal cortex, anterior cingulate, and orbitofrontal cortex. Results in disinhibition, apathy, executive dysfunction, and social-emotional deficits.
Semantic Variant PPA (svPPA): Targets anterior temporal lobe circuits bilaterally, causing loss of semantic knowledge and word meaning while sparing episodic memory and motor speech.
Non-Fluent Variant PPA (nfvPPA): Affects left inferior frontal gyrus and speech production networks, causing agrammatism and apraxia of speech while preserving semantic knowledge.
FTD with Motor Neuron Disease: Adds involvement of upper and lower motor neuron circuits, with corticospinal tract degeneration and fasciculations.
Progressive Supranuclear Palsy (PSP) affects brainstem and subcortical circuits, with the most characteristic involvement being the vertical gaze center and its connections[10]:
Corticobasal Syndrome (CBS) involves asymmetric cortical circuits with thalamocortical dysfunction[11]:
Multiple System Atrophy (MSA) combines basal ganglia, cerebellar, and autonomic circuit involvement[6:1]:
DLB shows distinctive circuit involvement reflecting its pathophysiological overlap between AD and PD[12]:
ALS affects motor circuits with additional involvement of frontotemporal circuits[13]:
Understanding circuit dysfunction enables targeted therapeutic approaches that aim to restore normal circuit function[14]:
DBS modulates abnormal circuit activity through implanted electrodes:
DBS works by delivering high-frequency electrical stimulation that inhibits or modulates the activity of neurons near the electrode contacts. The mechanism involves both local effects (direct neuronal inhibition, axonal activation) and network effects (changes in oscillatory activity throughout the connected circuit).
TMS provides non-invasive circuit modulation:
TMS induces electrical currents in the cortex through electromagnetic induction, modulating the excitability of cortical neurons and their connected circuits. Repeated sessions can produce lasting changes in circuit function through synaptic plasticity mechanisms.
Circuit-level pharmacology targets specific neurotransmitter systems:
Emerging circuit-targeted approaches:
Modern neuroscience employs multiple approaches to study neural circuits in neurodegeneration:
Neural circuits do not operate in isolation—they form an interconnected network where dysfunction in one circuit propagates to others:
Trans-synaptic propagation: Pathological proteins (tau, alpha-synuclein, TDP-43) spread along connected circuits, explaining the stereotyped progression of pathology and clinical symptoms.
Diaschisis: Dysfunction in one circuit can cause related circuits to become hypoactive due to loss of excitatory drive (e.g., hippocampal dysfunction causing DMN hypoconnectivity in AD).
Compensatory plasticity: Healthy circuits can compensate for damaged ones through increased activity or recruitment of alternative pathways, explaining the lag between pathology and clinical symptoms.
Network failure: When compensatory mechanisms are exhausted, network-level failure occurs rapidly, explaining the acceleration of clinical decline in moderate-to-severe disease stages.
Circuit dysfunction can be quantified using established clinical and neuroimaging measures:
Chen, X. et al. (2019). Circuit-level目标 in neurodegeneration. Nature Reviews Neuroscience. 2019. ↩︎
Chen, M. et al. (2021). Tau propagation along connected circuits in Alzheimer's disease. Neuron. 2021. ↩︎ ↩︎
Squire, L.R. & Zola, S.M. (1996). Structure and function of declarative and nondeclarative memory systems. Proceedings of the National Academy of Sciences. 1996. ↩︎
Kalia, L.V., & Lang, A.E. (2015). Parkinson's disease. The Lancet. 2015. ↩︎ ↩︎
Zhou, F. et al. (2018). Neural circuit vulnerability in frontotemporal dementia. Brain. 2018. ↩︎ ↩︎
Park, J. et al. (2020). Brainstem circuits in multiple system atrophy. Movement Disorders. 2020. ↩︎ ↩︎
Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica. 1991. ↩︎ ↩︎
Wang, Z. et al. (2022). Hippocampal-entorhinal circuit dysfunction in early Alzheimer's disease. Neurobiology of Aging. 2022. ↩︎
DeLong, M.R. & Wichmann, T. (2007). Circuits and circuit disorders of the basal ganglia. Archives of Neurology. 2007. ↩︎
Kim, S. et al. (2023). Cerebellar circuits in progressive supranuclear palsy. Movement Disorders. 2023. ↩︎
Yang, R. et al. (2023). Basal ganglia-thalamocortical circuits in corticobasal syndrome. Neurology. 2023. ↩︎
Walker, L. et al. (2022). Prodromal synapse loss in dementia with Lewy bodies circuits. Acta Neuropathologica. 2022. ↩︎
Smith, A. et al. (2023). Circuit dysfunction as biomarker in amyotrophic lateral sclerosis. Journal of Neurology. 2023. ↩︎
Nakagawa, T. et al. (2023). Transcranial magnetic stimulation for circuit restoration in neurodegeneration. Brain Stimulation. 2023. ↩︎
Huang, Y. et al. (2024). Deep brain stimulation for cognitive circuits in Alzheimer's disease. Nature Neuroscience. 2024. ↩︎